The prevalence of obesity and related metabolic disorders, particularly type 2 diabetes mellitus, is rising worldwide at an alarming rate. These used to mainly affect adults and older adults and were more prevalent in certain geographic regions; however, recent data confirm that a significant number of children and adolescents across the globe are also affected. Modern medicine has significantly improved in offering either medicinal and/or medical procedures to combat these health threats. At the same time, alternative and traditional medicine have also generously helped in the management of such disorders. In this paper, we summarize advances from the past 5 years in the applications of non-medicinal agents for the treatment and/or prevention of obesity and related metabolic disorders (particularly type 2 diabetes mellitus). In particular, the roles of anti-inflammatory, whole-food, and plant-based food diets, along with selected phytochemicals, certain gut bacterial species, and others are discussed.
Advances in the Management of Obesity and Type 2 Diabetes Mellitus: Recent Studies of Non-Medicinal Agents
Francesca Bonomini;
2025-01-01
Abstract
The prevalence of obesity and related metabolic disorders, particularly type 2 diabetes mellitus, is rising worldwide at an alarming rate. These used to mainly affect adults and older adults and were more prevalent in certain geographic regions; however, recent data confirm that a significant number of children and adolescents across the globe are also affected. Modern medicine has significantly improved in offering either medicinal and/or medical procedures to combat these health threats. At the same time, alternative and traditional medicine have also generously helped in the management of such disorders. In this paper, we summarize advances from the past 5 years in the applications of non-medicinal agents for the treatment and/or prevention of obesity and related metabolic disorders (particularly type 2 diabetes mellitus). In particular, the roles of anti-inflammatory, whole-food, and plant-based food diets, along with selected phytochemicals, certain gut bacterial species, and others are discussed.| File | Dimensione | Formato | |
|---|---|---|---|
|
CRDOJ.MS.ID.555985 -Sept 2025.pdf
gestori archivio
Descrizione: Curr res diab obesity 2025
Tipologia:
Full Text
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
455.03 kB
Formato
Adobe PDF
|
455.03 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


